Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 286

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 286
---
 holder of Series C Preferred Stock may convert all, or any part, of the outstanding Series C Preferred
Stock, at any time at such holder’s option, into shares of the Common Stock (which converted shares of Common Stock are referred
to as “Conversion Shares” herein) at the fixed “Conversion Price” of $5.82, which is subject to proportional
adjustment upon the occurrence of any stock split, stock dividend, stock combination and/or similar transactions.

Alternate Conversion Upon a Triggering Event. Following the occurrence and during the continuance of a Triggering Event (as defined below), each holder
may alternatively elect to convert the Series C Preferred Stock at the “Alternate Conversion Price” equal to the
lesser of:

| ● | the Conversion Price, and |

| ● | the greater of: |

| ● | the floor price of $0.0196; 
 and                         |

| ● | 80% of the volume weighted                                                                                    
 average price of the Common Stock during the 5 consecutive trading days immediately prior to such conversion. |

The Certificate of Designations
contains standard and customary triggering events (each, a “Series C Triggering Event”), including but not limited to: (i)
the suspension from trading or the failure to list the Common Stock within certain time periods; (ii) failure to declare or pay any dividend
when due; (iii) the failure to timely file or make effective a registration statement on Form S-1 pursuant to the Registration Rights
Agreement, dated as of September 25, 2024, by and between the Company and the holders of Series A Preferred Stock party thereto (the
“Second Registration Rights Agreement”), (iv) our failure to cure a conversion failure of failure to deliver shares of the
Common Stock under the Series C Warrants, or notice of our intention not to comply with a request for conversion of any Series C Preferred
Stock or a request for exercise of any Series C Warrants, and (iv) bankruptcy or insolvency of us.

<div align='center'>168</div>

If at the time of a conversion
the Alternate Conversion Price is determined to be the Floor Price because such Floor Price is greater than 80% of the five-day volume
weighted average price of a share of Common Stock, then the Conversion Amount (as defined in the Certificates of Designations), shall
automatically increase such that the shares of Series C Preferred Stock issuable upon such conversion are equal to the number of shares
of Common Stock that